Sphingosine 1-phosphate and cancer: Lessons from thyroid cancer cells

Biomolecules

Volumn 3, Issue 2, 2013, Pages 303-315

  Törnquist, Kid ^a,b  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

^b MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

Author keywords

Anaplastic; Cancer; Follicular; HERG; Sphingosine 1 phosphate; Sphingosine kinase; Thyroid

Indexed keywords

CYCLIN D1; GROWTH FACTOR RECEPTOR; INOSITOL 1, 4, 5 TRISPHOSPHATE; MYC PROTEIN; POTASSIUM CHANNEL HERG; PROTEIN C FOS; RHO FACTOR; SPHINGOMYELIN; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE KINASE; SPHINGOSYLPHOSPHORYLCHOLINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; CALCIUM HOMEOSTASIS; CELL MIGRATION; CELL PROLIFERATION; HUMAN; IMMUNOPRECIPITATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; THYROID CANCER;

EUKARYOTA;

EID: 84885910468     PISSN: None     EISSN: 2218273X     Source Type: Journal    
DOI: 10.3390/biom3020303     Document Type: Review

References (63)

1. Breslow, D.K.; Weissman, J.S. Membranes in balance: Mechanisms of sphingolipid homeostasis. Mol. Cell 2010, 40, 267-279.
2. Szabo, I.; Adams, C.; Gulbins, E. Ion channels and membrane rafts in apoptosis. Pflüegers Arch. 2004, 448, 304-312.
3. Hait, N.C.; Oskeritzian, C.A.; Paugh, S.W.; Milstien, S.; Spiegel, S. Sphingosine kinase, sphingosine 1-phosphate, apoptosis and diseases. Biochem. Biophys. Acta 2006, 1758, 2016-2026.
4. Beech, D.J. Integration of transient receptor potential canonical channels with lipids. Acta Physiol. (Oxf) 2012, 204, 227-237.
5. Törnquist, K. Sphingosine 1-phosphate, sphingosine kinase and autocrine calcium signalling in thyroid cells. Acta Physiol. (Oxf) 2012, 204, 151-157.
6. Pitson, S.M. Regulation of sphingosine kinase and sphingolipid signaling. Trends Biochem. Sci. 2010, 36, 97-107.
7. Hait, N.C.; Allegood, J.; Maceyka, M.; Strub, G.M.; Harikumar, K.B.; Singh, S.K.; Luo, C.; Marmorstein, R.; Kordula, T.; Milstien, S.; Spiegel, S. Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 2009, 325, 1254-1257.
8. Strub, G.M.; Paillard, M.; Liang, J.; Gomez, L.; Allegood, J.C.; Hait, N.C.; Maceyka, M.; Price, M.M.; Chen, Q.; Simpson, D.C., et al. Sphingosine-1-phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration. FASEB J. 2011, 25, 600-612.
9. Pappu, R.; Schwab, S.R.; Cornelissan, I.; Pereira, J.P.; Regard, J.B.; Xu, Y.; Camerer, E.; Zheng, Y.-W.; Huang, Y.; Cyster, J.G.; Coughlin, S.H. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science 2007, 316, 295-298.
10. Venkataraman, K.; Lee, Y.M.; Michaud, J.; Thangada, S.; Ai, Y.; Bonkovsky, H.L.; Parikh, N.S.; Habrukowich, C.; Hla, T. Vasular endothelium as a contributor of plasma sphingosine 1-phosphate. Circ. Res. 2008, 102, 669-679.
11. Murata, N.; Sato, K.; Tomura, H.; Yanagita, M.; Kuwabara, A.; Ui, M.; Okajima, F. Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochem. J. 2000, 352, 809-815.
12. Takabe, K.; Paugh, S.W.; Milstien, S.; Spiegel, S. "Inside-out" signaling of sphingosine 1-phosphate: Therapeutic implications. Pharmacol. Rev. 2008, 60, 181-195.
13. Strub, G.M.; Maceyka, M.; Hait, N.C.; Milstein, S.; Spiegel, S. Extracellular and intracellular actions of sphingosine-1-phosphate. Adv. Exp. Med. Biol. 2010, 688, 141-155.
14. Pyne, N.J.; Pyne, S. Sphingosine 1-phosphate and cancer. Nat. Rev. Cancer 2010, 10, 489-503.
15. Yester, J.W.; Tizazu, E.; Harikumar, K.B.; Kordula, T. Extracellular and intracellular sphingosine-1-phosphate in cancer. Cancer Metastasis Rev. 2011, 30, 577-597.
16. Törnquist, K.; Ekokoski, E. Effect of sphingosine derivatives on calcium fluxes in thyroid FRTL-5 cells. Biochem. J. 1994, 299, 213-218.
17. 2+ system in FRTL-5 thyroid cells: Possible involvement of guanosine triphosphate-binding proteins in the lipid signaling. Endocrinology 1997, 138, 220-229.
18. Törnquist, K.; Saarinen, P.; Vainio, M.; Ahlström, M. Sphingosine 1-phosphate mobilizes sequestered calcium, activates calcium entry, and stimulates DNA synthesis in thyroid FRTL-5 cells. Endocrinology 1997, 138, 4049-4057.
19. Björklund, S.; Palmberg, S.; Rask, S.; Westerdahl, A.-C.; Törnquist, K. Effects of sphingosine 1-phosphate on calcium signaling, proliferation, and S1P2 receptor expression in PC Cl3 rat thyroid cells. Mol. Cell. Endocrinol. 2005, 231, 65-74.
20. Mattie, M.; Brooker, G.; Spiegel, S. Sphingosine-1-phosphate, a putative second messenger, mobilizes calcium from internal stores via an inositol trisphosphate-independent pathway. J. Biol. Chem. 1994, 269, 3181-3188.
21. Högback, S.; Leppimäki, P.; Rudnäs, B.; Björklund, S.; Slotte, J.P.; Törnquist, K. Ceramide 1-phosphate increases intracellular free calcium concentrations in tyroid FRTL-5 cells. Evidence for an effect mediated by inositol 1,4,5-trisphosphate and intracellular sphingosine 1-phosphate. Biochem. J. 2003, 370, 111-119.
22. Meyer zu Heringdorf, D.; Lass, H.; Alemany, R.; Laser, K.T.; Neumann, E.; Zhang, C.; Schmidt, M.; Rauen, U.; Jakobs, K.H.; van Koppen, C.J. Sphingosine kinase mediated Ca2+ signalling by G-protein-coupled receptors. EMBO J. 1998, 17, 2830-2837.
23. Törnquist, K. Sphingosine 1-phosphate activates Na+-H+ exchange in thyroid FRTL-5 cells. Am. J. Physiol. 1997, 272, C1052-C1057.
24. Kimura, T.; Okajima, F.; Kikuchi, T.; Kuwabara, A.; Tomura, H.; Sho, K.; Kobayashi, I.; Kondo, Y. Inhibition of TSH-induced hydrogen peroxide production by TNFa through a sphingomyelinase signaling pathway. Am. J. Physiol. 1997, 273, E638-E643.
25. Kimura, T.O.F.; Sho, K.; Kobayashi, I.; Kondo, Y. Thyrotropin-induced hydrogen peroxide production in FRTL-5 thyroid cells is mediated not by adenosine 3',5'-monophosphate, but by Ca2+ signaling followed by phospholipase A2 activation and potentiated by an adenosine derivative. Endocrinology 1995, 136, 116-123.
26. Törnquist, K.; Malm, A.-M.; Kronqvist, R.; Pasternack, M.; Björklund, S.; Tuominen, R.; Slotte, J.P. Tumor necrosis factor a, sphingomyelinase and ceramide attenuate store-operated calcium entry in thyroid FRTL-5 cells. J. Biol. Chem. 1999, 274, 9370-9377.
27. Spiegel, S.; Milstien, S. Sphingosine-1-phosphate: An enigmatic signalling lipid. Nat. Rev. Mol. Cell Biol. 2003, 4, 397-407.
28. Balthasar, S.; Samulin, J.; Ahlgren, H.; Bergelin, N.; Lundqvist, M.; Toescu, E.C.; Eggo, M.C.; Törnquist, K. Sphingosine 1-phosphate receptor expression profile and regulation of migration in human thyroid cancer cells. Biochem. J. 2006, 398, 547-556.
29. Maceyka, M.; Harikumar, K.B.; Milstien, S.; Spiegel, S. Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol. 2012, 22, 50-60.
30. Guan, H.; Liu, L.; Cai, J.; Liu, J.; Ye, C.; Li, M.; Li, Y. Sphingosine kinase 1 is overexpressed and promotes proliferation in human thyroid cancer. Mol. Endocrinol. 2011, 25, 1858-1866.
31. Asghar, M.Y.; Viitanen, T.; Kemppainen, K.; Törnquist, K. Sphingosine 1-phosphate and human ether-a-go-go-related gene potassium channels modulate migration in human anaplastic thyroid cancer cells. Endoc-Relat. Cancer 2012, 19, 667-680.
32. Takuwa, N.; Du, W.; Kaneko, E.; Okamoto, H.; Yoshioka, K.; Takuwa, Y. Tumor-suppressive sphingosine-1-phosphate receptor-2 counteracting tumor-promoting sphingosine-1-phosphate receptor-1 and sphingosine kinase 1. Am. J. Cancer Res. 2011, 1, 460-481.
33. Bergelin, N.; Blom, T.; Löf, C.; Alam, C.; Balthasar, S.; Heikkilä, J.; Slotte, J.P.; Hinkkanen, A.; Törnquist, K. Sphingosine kinase as an oncogene: Autocrine sphingosine 1-phosphate enhances ML-1 thyroid carcinoma cell migration by a mechanism dependent on PKC-α and Erk1/2. Endocrinology 2009, 150, 2055-2063.
34. Xia, P.; Gamble, J.R.; Wang, L.; Pitson, S.M.; Moretti, P.A.; Wattenberg, B.W.; D'Andrea, R.J.; Vadas, M.A. An oncogenic role of sphingosine kinase. Curr. Biol. 2000, 10, 1527-1530.
35. Olivera, A.; Kohama, T.; Edsall, L.; Nava, V.; Cuvillier, O.; Poulton, S.; Spiegel, S. Sphingosine kinase expresion increases intracellular sphingosine-1-phosphate and promotes cell growth and survival. J. Cell Biol. 1999, 147, 545-558.
36. Ruckhäberle, E.; Rody, A.; Engels, K.; Gaetje, R.; von Minckwitz, G.; Schiffmann, S.; Grösch, S.; Geisslinger, G.; Holtrich, U.; Karn, T.; Kaufmann, M. Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. Breast Cancer Res. Treat. 2008, 112, 41-52.
37. Alvarez, J.; Milstien, S.; Spiegel, S. Autocrine and paracrine roles of sphingosine-1-phosphate. TRENDS Endocrinol. Metab. 2007, 18, 300-307.
38. Pyne, N.J.; Pyne, S. Receptor tyrosine kinase-G-protein-coupled receptor signalling platforms: Out of the shadow? Trends Pharmacol. Sci. 2011, 32, 443-450.
39. Takabe, K.; Kim, R.H.; Allegood, J.C.; Mitra, P.; Ramachandran, S.; Nagahishi, M.; Harikumar, K.B.; Hait, N.C.; Milstien, S.; Spiegel, S. Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2. J. Biol. Chem. 2010, 285, 10477-10486.
40. Sato, K.; Malchinkhuu, E.; Horiuchi, Y.; Mogi, C.; Tomura, H.; Tosaka, M.; Yoshimoto, Y.; Kuwabara, A.; Okajima, F. Citical role of ABCA1 transporter in sphingosine 1-phosphate release from astrocytes. J. Neurochem. 2007, 103, 2610-2619.
41. Pyne, N.J.; Waters, C.; Moughal, N.A.; Sambi, B.S.; Pyne, S. Receptor tyrosine kinase-GPCR signal complexes. Biochem. Soc. Trans. 2003, 31, 1220-1225.
42. Tanimoto, T.; Jin, Z.G.; Berk, B.C. Transactivation of vascular endothelial growth factor (VEGF) receptor Flk1/KFR is invovled in sphingosine 1-phosphate-stimulated phosphorylation of Akt and endothelial nitric-oxide synthase (eNOS). J Biol. Chem. 2002, 277, 42997-43001.
43. Waters, C.; Sambi, B.; Kong, K.C.; Thompson, D.; Pitson, S.M.; Pyne, S.; Pyne, N.J. Sphingosine 1-phosphate and platelet-derived growth factor (PDGF) act via PDGFβ receptor-sphingosine 1-phosphate receptor complex in airway smooth muscle cells. J. Biol. Chem 2003, 278, 6282-6290.
44. El-Shewy, H.M.; Johnson, K.R.; Lee, M.H.; Jaffa, A.A.; Obeid, L.M.; Luttrell, L.M. Insulin-like growth factors mediate heterotrimeric G protein-dependent Erk1/2 activation by transactivating sphingosine 1-phosphate receptors. J. Biol. Chem. 2006, 281, 31399-31407.
45. Miller, A.V.; Alvarez, S.E.; Spiege, S.; Lebman, D.A. Sphingosine kinase and sphingosine-1-phosphate are critical for transforming growth factor beta-induced extracellular signal-regulated kinase 1 and 2 activation and promotion of migration and invasion of esophageal cancer cells. Mol. Cell Biol. 2008, 28, 4142-4151.
46. Lebman, D.A.; Spiegel, S. Cross-talk at the crossroads of sphingosine-1-phosphate, growth factors, and cytokine signaling. J. Lipid Res. 2008, 49, 1388-1394.
47. Pyne, N.J.; Pyne, S. Sphingosine 1-phosphate, lysophosphatidic acid and growth factor signaling and termination. Biochi. Biophys. Acta 2008, 1781, 467-476.
48. Turner, H.E.; Harris, A.; Melmed, S.; Wass, J.A.H. Angiogenesis in endocrine tumors. Endocrine Rev. 2003, 24, 600-632.
49. Vieira, J.M.; Santos, S.C.R.; Espadinha, C.; Correia, I.; Vag, T.; Casalou, C.; Cavaco, B.M.; Catarino, A.S.; Dias, S.; Leite, V. Expression of vascular endothelial growth factor (VEGF) and its receptors in thyroid carcinomas of follicular origin: A potent autocrine loop. Eur. J. Endocrinol. 2005, 153, 701-709.
50. Kim, D.S.; Franklyn, J.A.; Boelaert, K.; Eggo, M.C.; Watkinson, J.C.; McCabe, C.J. Pituitary tumor transforming gene (PTTG) stimulates thyroid cell proliferation via vascular endothelial growth factor/kinesin insert domain receptor/inhibitor of DNA binding-3 autocrine pathway. J. Clin. Endocrinol. Metab. 2006, 91, 4603-4611.
51. Endo, A.; Nagashima, K.-I.; Kurose, H.; Mochizuki, S.; Matsuda, M.; Mochizuki, N. Sphingosine 1-phosphate induces membrane ruffling and increases motility of human umbilical vein endotjelial cells via vascular endothelial growth factor receptor and CRKII. J. Biol. Chem. 2002, 277, 23747-23754.
52. Igarashi, J.; Erwin, P.A.; Dantas, A.P.V.; Chen, H.; Michel, T. VEGF induces S1P1 receptors in endothelial cells: Implications for cross-talk between sphingolipid and growth factor receptors. Proc. Natl. Acad. Sci. USA 2003, 100, 10664-10669.
53. Hughes, S.K.; Wacker, B.K.; Kaneda, M.M.; Elbert, D.L. Fluid shear stress modulates cell migration induced by sphingosine 1-phosphate and vascular endothelial growth factor. Ann. Biomed. Eng. 2005, 33, 1004-1014.
54. Fieber, C.B.; Eldridge, J.; Taha, T.A.; Obeid, L.M.; Muise-Helmericks, R.C. Modulation of total Akt kinase by increased expression of a single isoform: Requirement of the sphingosine-1-phosphate receptor EDG3/S1P3, for the VEGF-dependent expression of Akt3 in primary endothelial cells. Exp. Cell Res. 2006, 312, 1164-1173.
55. Shu, X.; Wu, W.; Mosteller, R.D.; Broek, D. Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases. Mol. Cell. Biol. 2002, 22, 7758-7768.
56. Balthasar, S.; Bergelin, N.; Löf, C.; Vainio, M.; Andersson, S.; Törnquist, K. Interaction between sphingosine 1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid cancer cells. Endoc-Relat. Cancer 2008, 15, 521-534.
57. Bergelin, N.; Löf, C.; Balthasar, S.; Kalhori, V.; Törnquist, K. S1P1 and VEGFR-2 form a signaling complex with extracellular regulated kinase 1/2 and protein kinase C-α regulating ML-1 thyroid carcinoma cell migration. Endocrinology 2010, 151, 2994-3005.
58. Waters, C.M.; Connell, M.C.; Pyne, S.; Pyne, N.J. c-Src is involved in regulating signal transmission from PDGFβ receptor-GPCR(s) complexes in mammalian cells. Cell. Signal. 2005, 17, 263-277.
59. Sukocheva, O.; Wadham, C.; Holmes, A.; Albanese, N.; Verrier, E.; Feng, F.; Bernal, A.; Derian, C.K.; Ullrich, A.; Vadas, M.A.; Xia, P. Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor EDG-3: The role of sphingosine kinase-1. J. Cell Biol. 2006, 173, 301-310.
60. Arcangeli, A. Ion channels and transporters in cancer. 3. Ion channels in tumor cell-microenvironment cross talk. Am. J. Physiol. Cell Physiol. 2011, 301, C762-C771.
61. Jehle, J.; Schweizer, P.A.; Katus, H.A.; Thomas, D. Novel roles for HERG K+ channels in cell proliferation and apoptosis. Cell Death Dis. 2011, 2, e193.
62. Masi, A.; Bechetti, A.; Restano-Cassulini, R.; Polvani, S.; Hofmann, G.; Buccoliero, A.M.; Paglierani, M.; Pollo, B.; Taddei, G.L.; Gallini, P., et al. HERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines. Br. J. Cancer 2005, 93, 781-792.
63. Ramström, C.; Chapman, H.; Viitanen, T.; Afrasiabi, E.; Fox, H.; Kivelä, J.; Soini, S.; Korhonen, L.; Lindholm, D.; Pasternack, M.; Törnquist, K. Regulation of HERG (KCNH2) potassium channel surface expression by diacylglycerol. Cell. Mol. Life Sci. 2010, 67, 157-169.